Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

Liposome Preparation for the Analysis of Lipid-Receptor Interaction and Efferocytosis.

Voss OH, Lee HN, Tian L, Krzewski K, Coligan JE.

Curr Protoc Immunol. 2018 Feb 21;120:14.44.1-14.44.21. doi: 10.1002/cpim.43.

PMID:
29512142
2.

An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.

Gil-Krzewska A, Saeed MB, Oszmiana A, Fischer ER, Lagrue K, Gahl WA, Introne WJ, Coligan JE, Davis DM, Krzewski K.

J Allergy Clin Immunol. 2017 Dec 11. pii: S0091-6749(17)31887-0. doi: 10.1016/j.jaci.2017.10.040. [Epub ahead of print]

3.

The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Kim S, Easterling ER, Price LC, Smith SL, Coligan JE, Park JE, Brand DD, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

J Immunol. 2017 Oct 15;199(8):2692-2700. doi: 10.4049/jimmunol.1700271. Epub 2017 Sep 8.

PMID:
28887430
4.

Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation.

Lee HN, Tian L, Bouladoux N, Davis J, Quinones M, Belkaid Y, Coligan JE, Krzewski K.

J Clin Invest. 2017 May 1;127(5):1905-1917. doi: 10.1172/JCI89531. Epub 2017 Apr 17.

5.

Natural killer cell activity and dysfunction in Hermansky-Pudlak syndrome.

Gil-Krzewska A, Murakami Y, Peruzzi G, O'Brien KJ, Merideth MA, Cullinane AR, Gahl WA, Coligan JE, Gochuico BR, Krzewski K.

Br J Haematol. 2017 Jan;176(1):118-123. doi: 10.1111/bjh.14390. Epub 2016 Oct 21.

6.

Emerging role of CD300 receptors in regulating myeloid cell efferocytosis.

Voss OH, Tian L, Murakami Y, Coligan JE, Krzewski K.

Mol Cell Oncol. 2015 Jun 5;2(4):e964625. doi: 10.4161/23723548.2014.964625. eCollection 2015 Oct-Dec.

7.

Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock.

Voss OH, Murakami Y, Pena MY, Lee HN, Tian L, Margulies DH, Street JM, Yuen PS, Qi CF, Krzewski K, Coligan JE.

Immunity. 2016 Jun 21;44(6):1365-78. doi: 10.1016/j.immuni.2016.05.005. Epub 2016 May 31.

8.

Emerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune Homeostasis.

Wang H, Coligan JE, Morse HC 3rd.

Front Immunol. 2016 Mar 15;7:99. doi: 10.3389/fimmu.2016.00099. eCollection 2016. Review.

9.

Corrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.

Chen Z, Shojaee S, Buchner M, Geng H, Lee JW, Klemm L, Titz B, Graeber TG, Park E, Tan YX, Satterthwaite A, Paietta E, Hunger SP, Willman CL, Melnick A, Loh ML, Jung JU, Coligan JE, Bolland S, Mak TW, Limnander A, Jumaa H, Reth M, Weiss A, Lowell CA, Müschen M.

Nature. 2016 Jun 2;534(7605):138. doi: 10.1038/nature16997. Epub 2016 Mar 9. No abstract available.

PMID:
26958840
10.

Enhanced efferocytosis by dendritic cells underlies memory T-cell expansion and susceptibility to autoimmune disease in CD300f-deficient mice.

Tian L, Choi SC, Lee HN, Murakami Y, Qi CF, Sengottuvelu M, Voss O, Krzewski K, Coligan JE.

Cell Death Differ. 2016 Jun;23(6):1086-96. doi: 10.1038/cdd.2015.161. Epub 2016 Jan 15.

11.

Chediak-Higashi syndrome: Lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells.

Gil-Krzewska A, Wood SM, Murakami Y, Nguyen V, Chiang SCC, Cullinane AR, Peruzzi G, Gahl WA, Coligan JE, Introne WJ, Bryceson YT, Krzewski K.

J Allergy Clin Immunol. 2016 Apr;137(4):1165-1177. doi: 10.1016/j.jaci.2015.08.039. Epub 2015 Oct 21.

12.

CD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responses.

Moshkovits I, Karo-Atar D, Itan M, Reichman H, Rozenberg P, Morgenstern-Ben-Baruch N, Shik D, Ejarque-Ortiz A, Hershko AY, Tian L, Coligan JE, Sayós J, Munitz A.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8708-13. doi: 10.1073/pnas.1507625112. Epub 2015 Jun 29.

13.

The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development.

Kang X, Lu Z, Cui C, Deng M, Fan Y, Dong B, Han X, Xie F, Tyner JW, Coligan JE, Collins RH, Xiao X, You MJ, Zhang CC.

Nat Cell Biol. 2015 May;17(5):665-77. doi: 10.1038/ncb3158. Epub 2015 Apr 27.

14.

Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR.

Kubagawa H, Carroll MC, Jacob CO, Lang KS, Lee KH, Mak T, McAndrews M, Morse HC 3rd, Nolan GP, Ohno H, Richter GH, Seal R, Wang JY, Wiestner A, Coligan JE.

J Immunol. 2015 May 1;194(9):4055-7. doi: 10.4049/jimmunol.1500222.

15.

Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.

Chen Z, Shojaee S, Buchner M, Geng H, Lee JW, Klemm L, Titz B, Graeber TG, Park E, Tan YX, Satterthwaite A, Paietta E, Hunger SP, Willman CL, Melnick A, Loh ML, Jung JU, Coligan JE, Bolland S, Mak TW, Limnander A, Jumaa H, Reth M, Weiss A, Lowell CA, Müschen M.

Nature. 2015 May 21;521(7552):357-61. doi: 10.1038/nature14231. Epub 2015 Mar 23. Erratum in: Nature. 2016 Jun 2;534(7605):138.

16.

CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition.

Murakami Y, Tian L, Voss OH, Margulies DH, Krzewski K, Coligan JE.

Cell Death Differ. 2014 Nov;21(11):1746-57. doi: 10.1038/cdd.2014.86. Epub 2014 Jul 18.

17.

p85α recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression.

Tian L, Choi SC, Murakami Y, Allen J, Morse HC 3rd, Qi CF, Krzewski K, Coligan JE.

Nat Commun. 2014;5:3146. doi: 10.1038/ncomms4146.

18.

Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality.

Wu J, Tian L, Yu X, Pattaradilokrat S, Li J, Wang M, Yu W, Qi Y, Zeituni AE, Nair SC, Crampton SP, Orandle MS, Bolland SM, Qi CF, Long CA, Myers TG, Coligan JE, Wang R, Su XZ.

Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):E511-20. doi: 10.1073/pnas.1316467111. Epub 2014 Jan 13.

19.

Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells.

Peruzzi G, Femnou L, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, Coligan JE.

J Immunol. 2013 Aug 15;191(4):1883-94. doi: 10.4049/jimmunol.1300313. Epub 2013 Jul 12.

20.

LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity.

Krzewski K, Gil-Krzewska A, Nguyen V, Peruzzi G, Coligan JE.

Blood. 2013 Jun 6;121(23):4672-83. doi: 10.1182/blood-2012-08-453738. Epub 2013 Apr 30.

21.

Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses.

Choi SC, Wang H, Tian L, Murakami Y, Shin DM, Borrego F, Morse HC 3rd, Coligan JE.

J Immunol. 2013 Feb 1;190(3):987-96. doi: 10.4049/jimmunol.1202227. Epub 2012 Dec 24.

22.

Human NK cell lytic granules and regulation of their exocytosis.

Krzewski K, Coligan JE.

Front Immunol. 2012 Nov 9;3:335. doi: 10.3389/fimmu.2012.00335. eCollection 2012.

23.

Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells.

Murakami Y, Narayanan S, Su S, Childs R, Krzewski K, Borrego F, Weck J, Coligan JE.

J Immunol. 2012 Jul 15;189(2):587-97. doi: 10.4049/jimmunol.1200840. Epub 2012 Jun 6.

24.

Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells.

Simhadri VR, Andersen JF, Calvo E, Choi SC, Coligan JE, Borrego F.

Blood. 2012 Mar 22;119(12):2799-809. doi: 10.1182/blood-2011-08-372425. Epub 2012 Feb 1.

25.

Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype.

Tang X, Tian L, Esteso G, Choi SC, Barrow AD, Colonna M, Borrego F, Coligan JE.

J Immunol. 2012 Jan 15;188(2):548-58. doi: 10.4049/jimmunol.1102044. Epub 2011 Dec 7.

26.

Natural killer cells in healthy and diseased subjects.

Biassoni R, Coligan JE, Moretta L.

J Biomed Biotechnol. 2011;2011:795251. doi: 10.1155/2011/795251. Epub 2011 Aug 29. No abstract available.

27.

Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis.

Choi SC, Simhadri VR, Tian L, Gil-Krzewska A, Krzewski K, Borrego F, Coligan JE.

J Immunol. 2011 Oct 1;187(7):3483-7. doi: 10.4049/jimmunol.1101549. Epub 2011 Aug 24.

28.

Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.

Park YP, Choi SC, Kiesler P, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, Coligan JE.

Blood. 2011 Sep 15;118(11):3019-27. doi: 10.1182/blood-2011-04-346825. Epub 2011 Aug 3.

29.

CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection.

Silva R, Moir S, Kardava L, Debell K, Simhadri VR, Ferrando-Martínez S, Leal M, Peña J, Coligan JE, Borrego F.

Blood. 2011 Jun 2;117(22):5870-80. doi: 10.1182/blood-2010-09-310318. Epub 2011 Apr 11.

30.

Human Th1 cells that express CD300a are polyfunctional and after stimulation up-regulate the T-box transcription factor eomesodermin.

Narayanan S, Silva R, Peruzzi G, Alvarez Y, Simhadri VR, Debell K, Coligan JE, Borrego F.

PLoS One. 2010 May 13;5(5):e10636. doi: 10.1371/journal.pone.0010636.

31.

Endocytosis and intracellular trafficking of human natural killer cell receptors.

Masilamani M, Peruzzi G, Borrego F, Coligan JE.

Traffic. 2009 Dec;10(12):1735-44. doi: 10.1111/j.1600-0854.2009.00973.x. Epub 2009 Aug 5. Review.

32.

A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor-1 with collagens.

Tang X, Narayanan S, Peruzzi G, Apara A, Natarajan K, Margulies DH, Coligan JE, Borrego F.

J Immunol. 2009 May 1;182(9):5446-52. doi: 10.4049/jimmunol.0804052.

33.

Endocytosis as a mechanism of regulating natural killer cell function: unique endocytic and trafficking pathway for CD94/NKG2A.

Peruzzi G, Masilamani M, Borrego F, Coligan JE.

Immunol Res. 2009;43(1-3):210-22. doi: 10.1007/s12026-008-8072-7. Review.

34.

Endosomal trafficking of the ligated FcvarepsilonRI receptor.

Fattakhova GV, Masilamani M, Narayanan S, Borrego F, Gilfillan AM, Metcalfe DD, Coligan JE.

Mol Immunol. 2009 Feb;46(5):793-802. doi: 10.1016/j.molimm.2008.09.002. Epub 2008 Oct 22.

35.

Commonly used detergents.

Coligan JE.

Curr Protoc Immunol. 2001 May;Appendix 1:Appendix 1D. doi: 10.1002/0471142735.ima01ds17.

PMID:
18432640
36.

Commonly used detergents.

Coligan JE.

Curr Protoc Protein Sci. 2001 May;Appendix 1:Appendix 1B. doi: 10.1002/0471140864.psa01bs11.

PMID:
18429062
37.

Production of antipeptide antisera.

Coligan JE, Tam JP, Shao J.

Curr Protoc Neurosci. 2001 May;Chapter 5:Unit 5.6. doi: 10.1002/0471142301.ns0506s00. Review.

PMID:
18428505
38.

Uncommon endocytic and trafficking pathway of the natural killer cell CD94/NKG2A inhibitory receptor.

Masilamani M, Narayanan S, Prieto M, Borrego F, Coligan JE.

Traffic. 2008 Jun;9(6):1019-34. doi: 10.1111/j.1600-0854.2008.00738.x. Epub 2008 Mar 19.

39.

Commonly used detergents.

Coligan JE.

Curr Protoc Mol Biol. 2001 May;Appendix 1:Appendix 1I. doi: 10.1002/0471142727.mba01is43. Review.

PMID:
18265028
40.

The NKG2D receptor: immunobiology and clinical implications.

Burgess SJ, Maasho K, Masilamani M, Narayanan S, Borrego F, Coligan JE.

Immunol Res. 2008;40(1):18-34. doi: 10.1007/s12026-007-0060-9. Review.

PMID:
18193361
41.

Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors.

Marusina AI, Burgess SJ, Pathmanathan I, Borrego F, Coligan JE.

J Immunol. 2008 Jan 1;180(1):409-17.

42.

The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.

Sullivan LC, Clements CS, Beddoe T, Johnson D, Hoare HL, Lin J, Huyton T, Hopkins EJ, Reid HH, Wilce MC, Kabat J, Borrego F, Coligan JE, Rossjohn J, Brooks AG.

Immunity. 2007 Dec;27(6):900-11.

44.

The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Borrego F, Masilamani M, Marusina AI, Tang X, Coligan JE.

Immunol Res. 2006;35(3):263-78. Review.

PMID:
17172651
45.

CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse.

Masilamani M, Nguyen C, Kabat J, Borrego F, Coligan JE.

J Immunol. 2006 Sep 15;177(6):3590-6.

46.

The high-affinity immunoglobulin-E receptor (FcepsilonRI) is endocytosed by an AP-2/clathrin-independent, dynamin-dependent mechanism.

Fattakhova G, Masilamani M, Borrego F, Gilfillan AM, Metcalfe DD, Coligan JE.

Traffic. 2006 Jun;7(6):673-85.

47.

IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.

Burgess SJ, Marusina AI, Pathmanathan I, Borrego F, Coligan JE.

J Immunol. 2006 Feb 1;176(3):1490-7.

48.

The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B.

Lieto LD, Maasho K, West D, Borrego F, Coligan JE.

Genes Immun. 2006 Jan;7(1):36-43.

PMID:
16237464
49.

The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation.

Maasho K, Masilamani M, Valas R, Basu S, Coligan JE, Borrego F.

Mol Immunol. 2005 Aug;42(12):1521-30. Epub 2005 Feb 24.

PMID:
15950745
50.

NKG2D is a costimulatory receptor for human naive CD8+ T cells.

Maasho K, Opoku-Anane J, Marusina AI, Coligan JE, Borrego F.

J Immunol. 2005 Apr 15;174(8):4480-4.

Supplemental Content

Loading ...
Support Center